These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 30537997)

  • 1. Bidirectional gut-brain-microbiota axis as a potential link between inflammatory bowel disease and ischemic stroke.
    Zhao L; Xiong Q; Stary CM; Mahgoub OK; Ye Y; Gu L; Xiong X; Zhu S
    J Neuroinflammation; 2018 Dec; 15(1):339. PubMed ID: 30537997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diet-Microbiota Interactions in Inflammatory Bowel Disease.
    Sugihara K; Kamada N
    Nutrients; 2021 May; 13(5):. PubMed ID: 34062869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota in the pathogenesis of inflammatory bowel disease.
    Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
    Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Microbial Metabolites on Microbiota-Gut-Brain Axis in Inflammatory Bowel Disease.
    Banfi D; Moro E; Bosi A; Bistoletti M; Cerantola S; Crema F; Maggi F; Giron MC; Giaroni C; Baj A
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of intestinal microbiota and metabolites in inflammatory bowel disease.
    Dong LN; Wang M; Guo J; Wang JP
    Chin Med J (Engl); 2019 Jul; 132(13):1610-1614. PubMed ID: 31090547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Microbiome in Patients With Inflammatory Diseases.
    Somineni HK; Kugathasan S
    Clin Gastroenterol Hepatol; 2019 Jan; 17(2):243-255. PubMed ID: 30196163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in gut Microbiota mediated therapeutic targets in inflammatory bowel diseases: Emerging modalities for future pharmacological implications.
    Shamoon M; Martin NM; O'Brien CL
    Pharmacol Res; 2019 Oct; 148():104344. PubMed ID: 31400403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut Microbiota and Dietary Factors as Modulators of the Mucus Layer in Inflammatory Bowel Disease.
    Fernández-Tomé S; Ortega Moreno L; Chaparro M; Gisbert JP
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular vesicle-derived miRNA as a novel regulatory system for bi-directional communication in gut-brain-microbiota axis.
    Zhao L; Ye Y; Gu L; Jian Z; Stary CM; Xiong X
    J Transl Med; 2021 May; 19(1):202. PubMed ID: 33975607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gut-brain axis in irritable bowel syndrome and inflammatory bowel disease.
    Ancona A; Petito C; Iavarone I; Petito V; Galasso L; Leonetti A; Turchini L; Belella D; Ferrarrese D; Addolorato G; Armuzzi A; Gasbarrini A; Scaldaferri F
    Dig Liver Dis; 2021 Mar; 53(3):298-305. PubMed ID: 33303315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A murine model of pediatric inflammatory bowel disease causes microbiota-gut-brain axis deficits in adulthood.
    Salvo E; Stokes P; Keogh CE; Brust-Mascher I; Hennessey C; Knotts TA; Sladek JA; Rude KM; Swedek M; Rabasa G; Gareau MG
    Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G361-G374. PubMed ID: 32726162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bile Acid-Gut Microbiota Axis in Inflammatory Bowel Disease: From Bench to Bedside.
    Yang M; Gu Y; Li L; Liu T; Song X; Sun Y; Cao X; Wang B; Jiang K; Cao H
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease.
    Li L; Liu T; Gu Y; Wang X; Xie R; Sun Y; Wang B; Cao H
    Front Immunol; 2022; 13():974305. PubMed ID: 36211363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recipe for IBD: can we use food to control inflammatory bowel disease?
    Witkowski M; Witkowski M; Gagliani N; Huber S
    Semin Immunopathol; 2018 Feb; 40(2):145-156. PubMed ID: 29124320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut bacteria signaling to mitochondria in intestinal inflammation and cancer.
    Jackson DN; Theiss AL
    Gut Microbes; 2020 May; 11(3):285-304. PubMed ID: 30913966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Microbiome and Gut Inflammation].
    Autenrieth DM; Baumgart DC
    Dtsch Med Wochenschr; 2017 Feb; 142(4):261-266. PubMed ID: 28235226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota in inflammatory bowel diseases: moving from basic science to clinical applications.
    Collij V; Klaassen MAY; Weersma RK; Vila AV
    Hum Genet; 2021 May; 140(5):703-708. PubMed ID: 32857194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases.
    Sun M; Wu W; Liu Z; Cong Y
    J Gastroenterol; 2017 Jan; 52(1):1-8. PubMed ID: 27448578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Gut Microbiome and Inflammatory Bowel Diseases.
    Shan Y; Lee M; Chang EB
    Annu Rev Med; 2022 Jan; 73():455-468. PubMed ID: 34555295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory Bowel Diseases (IBD) and the Microbiome-Searching the Crime Scene for Clues.
    Lee M; Chang EB
    Gastroenterology; 2021 Jan; 160(2):524-537. PubMed ID: 33253681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.